In July 2019, the U.S. Food and Drug Administration (FDA) announced two innovation challenges to encourage the development of new approaches to contract sterilization of single-use medical devices. On November 25, 2019, the Agency announced that 46 applications were received as part of the challenge and 13 were selected. STERIS is excited to announce…
Details
Mark Botting, Director of Global Laboratories As part of our long-term commitment to supporting global medical device manufacturing, STERIS’s network of microbiological testing laboratories has continued to grow over the past year. New and expanded laboratories in the United States, Italy, and Germany broaden our capacity to deliver a range of testing services that support…
Details
As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the expansion of ethylene oxide (EO) contract sterilization services within its existing facilities in Kuala Ketil, Malaysia and Velka Bites, Czech Republic. The expansion of services in these regions furthers our commitment of ensuring patient safety through a…
Details
STERIS is pleased to announce the expansion of its existing Ontario, California, USA electron beam and gamma processing facility to include X-ray radiation technology.
Details
As part of our long-term commitment to supporting medical device manufacturing, STERIS is pleased to announce the expansion of its existing Libertyville South, Illinois, USA gamma processing facility to include X-ray radiation technology.
Details
we are excited to announce that we will be consolidating all existing brands within our business segment under the STERIS Applied Sterilization Technologies (AST) brand.
Details